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MaTissue tracking technologies such as speckle tracking echocardiography and feature tracking cardiac magnetic resonance
have enhanced the noninvasive assessment of myocardial deformation in clinical research and clinical practice.
The widespread enthusiasm for using tissue tracking techniques in research and clinical practice stems from the ready
applicability of these technologies to routine echocardiographic or cardiac magnetic resonance images. The technology is
common to both modalities, and derived parameters to describe myocardial mechanics are the similar, albeit with
different accuracies. We provide an overview of the normal values and reproducibility of the clinically applicable pa-
rameters, together with their clinical validation. The use of these technologies in different clinical scenarios, and the
additive value to current imaging diagnostics are discussed. (J Am Coll Cardiol Img 2015;8:1444–60) © 2015 by the
American College of Cardiology Foundation.O ptimal management of patients with car-diovascular disease is increasingly basedon algorithms that use cutoff values or
continuous variables, rather than simple binary
(“yes” or “no”) decision trees. Accordingly, cardiac
imaging techniques such as echocardiography and
cardiac magnetic resonance (CMR) imaging have
been developed for providing diagnostic information
that are often expressed numerically. Both tech-
niques can measure cardiac muscle motion and defor-
mation; however, more recently, the clinical focus
for noninvasive deformation imaging is moving
from tailored acquisitions, such as tissue Doppler
imaging or myocardial tagging, to post-processing
of standard grayscale B-mode or cine imaging, result-
ing in easier access and wider availability. This
review focuses on the current status of these post-
processing methods, commonly known as tissue
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relative strength and pitfalls and solutions that
address modality-related differences.
TECHNOLOGY OF TISSUE TRACKING
As shown in the Central Illustration, the technology of
tissue tracking refers to methods of identifying a
peculiar pattern along a curve on 1 image, such as the
endocardial border, and recognizing the same pattern
within a second image taken a few instants later. In
this way, displacement of myocardial segments can
be estimated. In echocardiography, images are char-
acterized by the presence of speckles with a certain
persistence (1,2); thus, the technique is commonly
referred to as speckle tracking echocardiography (STE)
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AB BR E V I A T I O N S
AND ACRONYM S
2D = 2-dimensional
3D = 3-dimensional
ARVC = arrhythmogenic right
ventricular cardiomyopathy
AS = aortic stenosis
CAD = coronary artery disease
CMR = cardiac magnetic
resonance
CP = constrictive pericarditis
CRT = cardiac
resynchronization therapy
DCM = dilated cardiomyopathy
EF = ejection fraction
FT = feature tracking
GCS = global circumferential
strain
GLS = global longitudinal
strain
GRS = global radial strain
HCM = hypertrophic
cardiomyopathy
HFpEF = heart failure with
preserved ejection fraction
HFrEF = heart failure with
reduced ejection fraction
LA = left atrium
LS = longitudinal strain
LV = left ventricle
LVT = left ventricular twist
MR = mitral regurgitation
PAH = primary arterial
hypertension
RCM = restrictive
cardiomyopathy
RV = right ventricle
STE = speckle tracking
cardiography
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1445regions are identiﬁed by individual anatomical
features, they are usually referred to as feature
tracking (FT) (3).Thus, the intrinsic differences in
both techniques are related to what region of myocar-
dium is tracked, which may lead to differences in
measurements.
All tracking techniques are more robust and
reproducible for global rather than regional values.
Dependent on image quality, 2D-STE is making it
difﬁcult in instances of poor echogenic windows, ul-
trasound dropouts, and reverberations. Through-
plane motion may limit measurements in 2D-STE
due to difﬁculties in tracking speckles that fall out of
plane in subsequent tracking frames. In the distal part
of the ultrasound sector, image quality deteriorates,
resulting in a better tracking quality of speckles that
are located proximally (4).
The problem of through-plane motion can be solved
by using 3D echocardiographic techniques (i.e., 3D-
STE) that recently became possible with advance-
ments in matrix-array ultrasound transducers. In
principle, the same tracking technology can be applied
to 3D volumetric regions without conceptual differ-
ences, resulting in the availability of several 3D tissue
tracking solutions. Unlike 2D-STE, speckles can be
tracked simultaneously in all directions to derive all
deformation parameters, alleviating the effect of
through-plane motion and allowing for assessment of
speckles independent from speciﬁc imaging planes.
However, 3D images present a substantially (at least
3 to 4) lower spatial as well as lower temporal res-
olution than their 2D counterpart does. This limitation
in combination with the remaining dependency of the
data on image quality so far makes 3D-STE assess-
ments still controversial and their true value remains
unknown (5). Further technical developments are
required for improving 3D-STE accuracy.
FT-CMR has been explored on stacks of 2D cine
images, with a typical slice distance of 6 to 8 mm and
strong contrast between blood pool and myocardium,
but with a lower in-plane spatial (1 to 2 mm) and
temporal resolution (commonly 30 phases per heart
cycle) than with 2D-STE. FT-CMR on 2D stacks suffers
also from through-plane motion effects. Temporal
averaging may result in lower strain values for FT-
CMR in comparison to STE. Due to the lack of intra-
myocardial features, FT-CMR algorithms focus on the
endocardial and epicardial borders with a stronger
weighing of endocardial deformation explaining
some of the differences in results found in direct
comparisons of FT-CMR and STE. From the displace-
ment estimations provided by these tracking meth-
odologies a series of deformation parameters relevantto assess the mechanics of the myocardium
can be derived (Table 1).
NORMAL VALUES, REPRODUCIBILITY,
AND CLINICAL VALIDATION
Tissue tracking can be used in the assessment
of the mechanics of all cardiac chambers.
Whereas theassessmentof left ventricular (LV)
and right ventricular (RV) deformations are of
established clinical beneﬁt, tissue tracking has
been also used in studies to assess atrial de-
formations, mostly of the left atrium (LA);
however, clinical applications remain to be
validated.
SPECKLE TRACKING ECHOCARDIOGRA-
PHY. Global longitudinal strain (GLS) aver-
aged from the apical views is the most robust
and reproducible of all LV deformation pa-
rameters and has been shown to be a power-
ful diagnostic and prognostic tool. The use of
LV- and RV-GLS is recommended in most
recent guidelines for the quantitative
assessment of LV and RV function (6). Due to
a wide range of normal cutoff values (17.3%
to 21.5%) when measured by different ven-
dors (6), guidelines are not recommending a
clear cutoff value for LV-GLS but suggest that
peak systolic LV-GLS in a healthy individual
should be approximately –20%. Lower values
should be expected in male patients and with
increasing age and heart rate, as well as
loading conditions, will inﬂuence the results
(6,7). Serial measurements in an individual
patient should be carried out using the same
vendor machine and software (6).
RV-GLS and strain rate can be derived from
tracking the RV free wall and the LV septum or
only from the RV free wall in a RV focused
apical 4-chamber view; however, RV free wall mea-
surements were found to be of more prognostic value
(6). Pooled data from single-center studies suggest that
normal RV-GLS derived from the free wall should be
lower than –20% (6).
It is important to note that GLS has better repro-
ducibility than other LV deformation indices. Normal
values of global circumferential strain (GCS) range
between 20.9% and 27.8%, and global radial strain
(GRS) between 35.1% and 59.0%, with mean values
of 23.3% and 47.3%, respectively (8). The assess-
ment of LV rotational mechanics suffers additionally
from the lack of a standardized method of LV apical
short-axis acquisition. Only small studies deﬁning
echo
CENTRAL ILLUSTRATION Current Tissue Tracking Technology to Assess Early Myocardial Dysfunction
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TABLE 1 Main Clinically Applicable Cardiac Mechanics Variables Derived From Tracking Technology
Deﬁnition Parameters
Displacement, cm Distance between instantaneous and initial (often
end-diastolic) position of a myocardial segment
Longitudinal displacement
Radial displacement
Circumferential displacement
Velocity, cm/s Velocity of displacement (displacement/time)
accuracy is highly frame-rate dependent
Longitudinal velocity
Radial velocity
Circumferential velocity
Strain, % Change in length of an object within a certain
direction relative to its initial (often end-
diastolic) length
Global/segmental longitudinal strain (GLS/LS)
Global/segmental radial strain (GRS/RS)
Global/segmental circumferential strain (GCS/CS)
Strain rate, 1/s The speed of deformation accuracy is highly
frame-rate dependent
Peak systolic global longitudinal strain rate (GLSR-S)
Early diastolic global longitudinal strain rate (GLSR-E)
Late diastolic global longitudinal strain rate (GLSR-A)
Peak systolic global radial strain rate (GRSR-S)
Early diastolic global radial strain rate (GRSR-E)
Late diastolic global radial strain rate (GRSR-A)
Peak systolic global circumferential strain rate (GCSR-S)
Early diastolic global circumferential strain rate (GCSR-E)
Late diastolic global circumferential strain rate (GCSR-A)
Rotation Results from shortening and lengthening of
helically oriented myocardial ﬁbers causing
counterclockwise rotation of the apex and
clockwise rotation of the base as viewed from
the apex
Peak systolic apical rotation (apical-R)
Peak systolic basal rotation (basal-R)
LV twist (LVT)
LV torsion (LV-tor)
Percentage of LV untwist at mitral valve opening (%LV-UT-MVO)
LV untwist rate (LV-UTR)
Time to peak untwist (TTP-UT)
LV ¼ left ventricular.
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(LVT) and untwist are available. Therefore, GCS, GRS,
and LVT remain deformation parameters with po-
tential clinical value awaiting further validation.
CMR FEATURE TRACKING. Comparative normal
values can be found in Table 2. For this review we
included data from studies that have reported more
than 1 strain component.
Across normal value studies, the most consistent
parameters were GCS and GLS. In contrast, variations
in GRS between studies were large and radial
strains measured from long-axis acquisitions were
often lower than from short-axis acquisitions,
possibly attributed to through-plane motion in
the short-axis scans. Normal values do not depend
on ﬁeld strength (9) when acquired with similar
acquisition parameters including similar spatial res-
olution. So far no systematic studies have been per-
formed to assess sex or age differences for FT-CMRTissue Tracking technologies such as speckle tracking echocardiography
noninvasive assessment of myocardial mechanics of all cardiac chamber
myocardial motion and deformation (e.g., velocities, strain-rates, and st
strain (GCS) have proven to be robust and reproducible in clinical pract
Global radial strain (GRS) and twist can be assessed, but are less reprod
mechanics in pathology (subclinical) with normal or preserved ejection
(i.e., subendocardial vs. subepicardial vs. transmural involvement) of th
identifying cohorts of patients with similar presentations, prognosis, an
CENTRAL ILLUSTRATION Continueddeformation parameters or dependency on imaging
parameters.
RV circumferential and radial strain and strain-rate
values showed overall lower values than their LV
counterparts did (10). This is consistent with RV
geometrical features, having thinner walls and larger
radius of curvature of the free wall.
Normal values for LA-GLS can be derived during
the reservoir (29  5%), conduit (21  6%), and atrial
contraction phases (8  3%) of the atrial deformation
and show an increase in atrial contraction in elderly
subjects consistent with physiology of normal aging
(11,12).
The reproducibility studies and clinical validation
are discussed in the Online Appendix and Online
Tables 1 to 3.
Summary: Deriving normal values for different
deformations studied by STE and FT-CMR is not easy
because of variability among studies and different(STE) or more recently feature tracking cardiac magnetic resonance (FT-CMR) enhance the
s in clinical research and enter clinical practice. Whereas a plethora of parameters describing
rain) are available, only global longitudinal strain (GLS) and global circumferential
ice with current implementations of these technologies and current image acquisition.
ucible. Increasingly, these technologies contribute to detect early changes in myocardial
fraction (EF). In the progression to heart failure, different transmural myocardial involvement
e disease will lead to different responses in global strain components. This may allow for
d response to therapy.
TABLE 2 Overview of Normal Values for FT-CMR
First Author, Year (Ref. #) n GCS (SAX) GRS (SAX) GRS (LAX) GLS (LV) GLS (RV) GCS (RV) GRS (RV)
Augustine et al., 2013 (86) 145 21  3 25  6 — 19  3 — — —
Schuster et al., 2011 (98) 10 24  7 20  15 15  10 16  10 20  14 — —
Schuster et al., 2013 (9)
1.5-T 10 20  8 25  12 17  10 19  11 21  15 — —
3.0-T 10 19  10 23  11 15  9 20  10 22  12 — —
Morton et al., 2012 (87);
average of 3 studies
10 17  5 19  7 18  6 20  5 22  6 — —
Kutty et al., 2013 (88) 20 25  2 50  12 — 20  5 — — —
Kempny et al., 2012 (76) 26 24  6 28  11 — 21  3 24  4 — —
Padiyath et al., 2013 (89) 20 25  3 51  12 — 20  5 20  4 — —
Heermann et al., 2014 (10) 10 — — — — 19  6 10  4 14  6
Values are n or mean  SD. Dashes indicate data are not available.
CMR ¼ cardiac magnetic resonance; FT ¼ feature tracking; GCS ¼ global circumferential strain; GLS ¼ global longitudinal strain; GRS ¼ global radial strain; LAX ¼ measured
on long-axis slice; LV ¼ left ventricle; RV ¼ right ventricle; SAX ¼ measured in short-axis slice.
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1448users. GLS is the most robust deformation parameter
for STE and is recommended in current guidelines
for the assessment of LV function. Normal values
around –20% for the LV and lower than –20% for the
RV have been recommended for clinical practice. For
FT-CMR, GCS is more reproducible than GLS with
similar normal values as STE. Radial strain shows
large ranges between studies and variability of
segmental strains remains too high to use them as
single clinical measures.
TRANSMURALITY OF DYSFUNCTION
CORRESPONDS TO PATTERNS OF
MYOCARDIAL DEFORMATION
Myocardial dysfunction can be classiﬁed according to
the involved myocardial layer into predominantly
subendocardial myocardial dysfunction, transmural
myocardial dysfunction, and subepicardial dysfunc-
tion (Central Illustration) (13). This classiﬁcation
scheme corresponds to the structural and functional
subunits of the LV that govern systolic and diastolic
performance (13), both of which depend on the
functional integrity and the synergistic coupling of
the subendocardial and subepicardial ﬁbers’ layers.
Using the transmurality of myocardial involvement
allows identifying cohorts of patients with similar
presentations, prognosis, and response to therapy.
Noninvasive imaging techniques currently do not
assess myocardial ﬁber mechanics. However, layer-
speciﬁc strain measurements are being developed
and awaiting clinical validation. The differences
in direction of the subendocardial and subepicardial
ﬁbers have been related to the components of
myocardial deformation for deﬁning the transmural
extent of myocardial dysfunction (Central Illustration).Contraction of the subendocardial ﬁbers contributes
to longitudinal shortening, whereas contraction of the
subepicardial ﬁbers contributes to circumferential
shortening. Both aspects contribute to radial thick-
ening. Myocardial rotation due to shearing forces
created by sliding of myocardial ﬁbers in the
longitudinal-circumferential direction is dominated
by the subepicardial layer because of the larger radius
of rotation (14).
Most progressive myocardial diseases predomi-
nantly cause subendocardial dysfunction in their early
stages, leading to reduction in longitudinal LV me-
chanics (15). Because epicardial ﬁbers remain spared,
circumferential strain and twist mechanics of the LV
show normal or even increased values, compensating
for the longitudinal mechanical dysfunction and thus
preserve stroke volume and ejection fraction (EF).
Given the coronary anatomy, ischemia causes mainly
subendocardial ﬁber dysfunction, for example, in the
presence of increased LV afterload. The development
of subepicardial hypertrophy attempts to compen-
sate for the loss of longitudinal function and
reduce subendocardial wall stress, which in turn
leads to the increased circumferential and rotational
mechanics (16). Blood pressure control in hypertensive
patients has been shown to reduce circumferential
strain and LVT values with concomitant regression of
subepicardial hypertrophy (17).
Transmural involvement results in concomitant
subendocardial and subepicardial dysfunction re-
sulting in attenuation of myocardial mechanics in all
directions (13), with impairment of LV ejection per-
formance. An acute large transmural infarction is a
classic example where simultaneous impairment of
LV longitudinal and circumferential mechanics is
seen, resulting in LV systolic dysfunction.
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1449Summary: Myocardial dysfunction can be classi-
ﬁed according to the extent of endocardial or trans-
mural involvement. Endocardial involvement results
in worsening of longitudinal involvement, whereas
other components may remain preserved, thereby
preserving EF. Whereas transmural dysfunction leads
to loss of myocardial mechanics in all directions,
resulting into LV dilation and reduction of LVEF.
SPECIFIC CLINICAL SCENARIOS
SUBCLINICAL MYOCARDIAL DYSFUNCTION. The
longstanding presence of cardiovascular risk factors
such as hypertension, diabetes mellitus, and obesity
may cause disruption in the myocardial interstitial
matrix as a result of microvascular ischemia, intra-
myocardial ﬁbrosis, or collagen degradation product
accumulation, leading to microscopic structural
changes of the myoﬁber (18–20). These changes usu-
ally result in subclinical myocardial dysfunction at
the endocardial level that can be detected using strain
imaging as described earlier (reduction in GLS with
compensatory increase in GCS and LVT with deteri-
oration of diastolic function) (13). It is to be noted that
similar changes also occur during the early subclinical
stages and mild cases of inﬁltrative cardiac diseases.
Because GLS is more reproducible and less variable
than other parameters are and has proven clinical
value, it is probably the single most important vari-
able that can be used to identify and follow-up these
patients.
Summary: Long-standing risk factors cause micro-
scopic changes at the cellular level that affect the
endocardial layer leading to depressed GLS and GRS,
whereas GCS and LVT are relatively preserved due to
the spared epicardial layer. GLS is of particular value
in identifying and monitoring serial changes in these
patients.
CORONARY ARTERY DISEASE. In patients with cor-
onary artery disease (CAD), STE imaging has been
applied extensively to reduce interobserver vari-
ability, to provide absolute cutoff values, and to
assess “functional” transmurality of an infarction.
Whereas visual assessments of regional systolic
function, such as wall motion score index, are
accepted methods of assessing myocardial ischemia
and coronary heart disease, both at rest and during
stress testing, these methods are greatly variable be-
tween readers and are expertise-demanding. On the
other hand, 2D-STE strain imaging offers a relatively
more robust and simpler method of assessing global
and regional functions in patients with coronary heart
disease at rest and during stress testing, allowing forless variability in the assessment of hypokinetic and
dyskinetic segments (21).
Given the predominantly subendocardial involve-
ment in ischemia, reduction of global and segmental
GLS is an early abnormality seen in patients with
CAD (Figures 1A and 1C). Reduced GLS can be used to
diagnose CAD and the location of myocardial infarc-
tion (22), whereas augmentation of GLS during
dobutamine stress echocardiography indicates global
myocardial viability (Figures 1B and 1D). Segmental
assessment of longitudinal strain (LS) is superior to
visual assessment in identifying viable myocardial
segments during low-dose dobutamine echocardiog-
raphy (23), can be used to identify ischemic territories
(24) and segments with ischemia-related post-systolic
shortening (25,26), and to estimate infarct size.
Numerous studies have suggested clinical utility
of regional strain in CAD (Table 3); however,
improvement in the precision of regional strain will
be required for making this technique clinically
useful.
Summary: GLS can be effectively used in CAD and
myocardial infarction for identifying ischemic terri-
tories and infarct size, respectively. Improvement of
GLS and segmental LS values with dobutamine infu-
sion is suggestive of global and segmental viability.
Scarred and ischemic segments are associated with a
reduction in other deformation parameters. Circum-
ferential strain and LVT is preserved in sub-
endocardial ischemia and is reduced in patients with
transmural ischemia and infarction.
CARDIOMYOPATHIES. Dilated cardiomyopathy. Di-
lated cardiomyopathy (DCM) can be idiopathic or
secondary to a variety of causes including ischemic
heart disease, alcohol consumption, peripartum,
chemotherapy, ventricular noncompaction, sarcoid-
osis, hemochromatosis, and myocarditis. The signif-
icant transmural myocardial remodeling that occurs
in these patients is usually accompanied by loss of
myocardial mechanics in all directions in parallel to
the severity of LV systolic dysfunction. Both STE and
FT-CMR studies have shown that the depressed GLS
in these patients is of particular prognostic value
and can be used to assess response to therapy and
predict the occurrence of major cardiovascular
events (27).
In addition to the abnormal strain values in
patients with DCM, the increased sphericity of the
LV apex affects the overall rotational mechanics and
is usually accompanied by signiﬁcant decrease in
apical rotation and overall LVT. LV rotational me-
chanics, in addition to GLS, are other potential pre-
dictors of the response to cardiac resynchronization
FIGURE 1 STE in a Patient With Ischemic Cardiomyopathy During Low-Dose Dobutamine Viability Study
Polar maps at baseline (A) and peak dobutamine dose (B). Strain curves at baseline (C) and peak dobutamine dose (D). (A,B) Compared
with baseline, segmental strain variables after dobutamine increased in the basal lateral and basal and mid anterior wall segments as well
the basal posterior septum and basal and mid inferior wall segments, which is suggestive of viability. Moreover, strain in all directions (GLS,
GCS, and GRS) increased at peak dobutamine compared with their baseline values, which is also suggestive of viability. ANT ¼ anterior;
GCS ¼ global circumferential strain; GLS ¼ global longitudinal strain; GRS ¼ global radial strain; INF ¼ inferior; LAT ¼ lateral; POST ¼ posterior;
SEPT ¼ septal; STE ¼ speckle tracking echocardiography.
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(28,29).
Using FT-CMR, it was found that GLS is an inde-
pendent predictor of survival in DCM and has incre-
mental information for risk stratiﬁcation beyond
clinical parameters, biomarker, and standard CMR
(30). STE-based studies found that strain can be a
sensitive tool in early detection of cardiotoxicity
especially in cancer patients being treated with
chemotherapy. In female breast cancer patients
treated with anthracyclines, GLS in combination with
ultrasensitive troponin I was found to be predictive of
the occurrence of chemotherapy-induced cardiotox-
icity after 15 months of the completion of anthracy-
clines (31). GLS was also an independent predictor of
LVEF in female breast cancer patients treated withtrastuzumab (32). A recent systematic review found
that early reduction of GLS by 10% to 15% is the most
useful parameter in prediction of cardiotoxicity in
patients receiving cancer chemotherapy (33).
In patients requiring CRT, an increase in GLS after
implantation, in addition to the standard echocar-
diographic measurements, was found to predict re-
sponders and all-cause mortality at 1-year follow-up
(34). A combined index of the magnitude and time
of segmental radial strain was also found to be
predictive of responders and survival 6 months
post-implantation (35). Because of its ability to map
temporal changes of strain distribution over the
entire LV chamber, 3D-STE is considered a better
modality for the analysis of LV dyssynchrony than
2D-STE is (36). Therefore, 3D-STE strain mapping may
TABLE 3 Tissue Tracking Technology in CAD
First Author, Year (Ref. #) Patient Subgroup Technology Major Finding
Vitarelli et al., 2013 (62) Chronic stable angina 2D-STE GLS is better predictor of CAD severity than exercise ECG is
Sarvari et al., 2013 (90) Non-STEMI 2D-STE Subendocardial layer-speciﬁc strain is more depressed with
signiﬁcant CAD
Ersbøll et al., 2013 (91) STEMI with preserved EF 2D-STE GLS is better predictor of events than traditional risk factors are
Haugaa et al., 2010 (92)
Ersbøll et al., 2013 (93)
Acute STEMI 2D-STE Mechanical dispersion is predictive of sudden cardiac death or
sustained VT
Shimoni et al., 2011 (94) Coronary artery disease 2D-STE All components of strain and strain rate are reduced and delayed in
ischemic and scarred segments
Omar et al., 2015 (21) ICM normal EF 2D-STE LVT is preserved with subendocardial ischemia and reduced with
transmural ischemia
Park et al., 2012 (95) Acute STEMI 2D-STE Apical rotation and LVT are reduced. LVT predicts functional recovery
after 6 months
Seo et al., 2009 (96) ICM 3D-STE 3D-STE conﬁrms the extent of myocardial ischemia. Larger validation
studies are lacking
Schneeweis et al., 2014 (97) ICM FT-CMR FT-CMR improves diagnostic accuracy during dobutamine stress CMR
Schuster et al., 2011 (98) ICM FT-CMR FT-CMR–derived parameters during low-dose dobutamine quantify the
detection of myocardial viability and transmurality of infarction
Maret et al., 2009 (99) Post-STEMI FT-CMR Radial strain is more predictive for scar transmurality than longitudinal
endocardial strain is
2D ¼ 2-dimensional; 3D ¼ 3-dimensional; CAD ¼ coronary artery disease; ECG ¼ electrocardiography; EF ¼ ejection fraction; ICM ¼ ischemic cardiomyopathy; LVT ¼ left
ventricular twist; STE ¼ speckle tracking echocardiography; STEMI ¼ ST-segment elevation myocardial infarction; VT ¼ ventricular tachycardia; other abbreviations
as in Table 2.
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response after CRT, but more studies and de-
velopments are needed.
Summary: DCM is associated with a signiﬁcant
decrease of myocardial deformation in all directions.
GLS is of particular clinical value being able to
monitor response to therapy, predict future events,
and response to CRT.
Hypertrophic cardiomyopathy. Both ﬁbrosis and hyper-
trophy contribute to abnormal myocardial mechanics
in patients with hypertrophic cardiomyopathy (HCM).
The increased wall stress and the relative endocardial
ischemia together with the ﬁbrotic changes lead to
endocardial dysfunction and thus a prominent
decrease in GLS (Central Illustration). Therefore, GLS
can be effectively used to differentiate pathological
hypertrophy from physiological hypertrophy that
occurs in conditioned hearts of trained athletes, who
show normal GLS values. Longitudinal septal strain,
in particular, was found to be inversely related to
the ﬁbrotic changes in histopathology and to be a
more powerful predictor of arrhythmia than late
gadolinium enhancement is (37). GLS was also
shown to predict adverse events in adults with HCM
(38). The endocardial dysfunction noticed in HCM
leads to depression of GRS; however, because of the
epicardial layer thickening, these patients usually
have increased LVT with delayed LV untwist (39). In 1
report (40), surgical myomectomy was found to
normalize GCS and LVT in these patients.Using FT-CMR, it was reported that patients with
HCM have reduced longitudinal, radial, and circum-
ferential strains compared with control subjects with
the ability of radial and longitudinal strain to pre-
dict clinical outcome (41). Similar to STE studies,
FT-CMR–derived LVT was found to be increased in
patients with HCM, whereas LV untwist was delayed.
In addition, peak LVT was signiﬁcantly and
independently related to the percentage of LV late
gadolinium enhancement as well as myocardial
thickness (42).
Summary: In patients with HCM, endocardial
dysfunction causes decreased GLS and GRS, whereas
the epicardial thickening leads to preserved GCS and
LVT. GLS can be used to predict future response and,
more importantly, to differentiate LV hypertrophy in
HCM from that in athletes’ hearts.
Restrictive cardiomyopathy. Restrictive cardiomyopa-
thy (RCM) is caused by several inﬁltrative and
storage diseases such as amyloidosis, sarcoidosis,
systemic sclerosis, ﬁbroelastosis, hemochromatosis,
endomyocardial ﬁbrosis, and eosinophilic endomyo-
cardial disease (43). The microscopic deposition of
these materials results in increased myocardial stiff-
ness, which causes impaired ventricular ﬁlling with
normal or decreased diastolic volume of either or
both. Wall thickness may be normal or increased
depending on the underlying cause.
Whatever the cause of RCM, GLS is always
decreased. Myocardial GRS and GCS in RCM
FIGURE 2 Use of STE Parameters to Differentiate Between RCM and CP
(A to C) In restrictive cardiomyopathy (RCM), the subendocardial ﬁber dysfunction will be associated with depressed GLS and GRS, whereas the spared epicardial ﬁbers
will lead to normal or increased GCS, left ventricular (LV) torsion, and LV torsional rate. (D to F) In constrictive pericarditis (CP), GLS and GRS are normal due to the
spared endocardial ﬁbers, whereas the affected epicardial ﬁbers will be associated with depressed GCS, LV torsion, and LV torsional rate. Abbreviations as in Figure 1.
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1452may remain compensated (44), and if impaired
(45), will be related to the extent of cardiac involve-
ment (46).
The most investigated cause of RCM is amyloid-
osis. Overall, GLS is decreased in amyloid heart dis-
ease as expected in a case of RCM and was found to be
a negative predictor of survival (47). However, GLS in
cardiac amyloidosis has a characteristic pattern with
reduced strain at the LV base and progressively
increased strain near the LV apex. LV twisting and
untwisting motions are initially increased in patients
with light-chain amyloidosis or systemic amyloidosis
with no cardiac involvement (48,49), but they may
normalize or become reduced with ongoing cardiac
involvement (48). This may be helpful in differenti-
ating amyloid-associated cardiac hypertrophy from
HCM (46).In patients with endomyocardial ﬁbrosis (Fabry
disease), in addition to the lower GLS (50), diastolic
strain rates are also reduced (51,52), which correlated
with the late gadolinium enhanced CMR (50). In pa-
tients with sarcoidosis and systemic sclerosis (53),
GLS is also signiﬁcantly reduced, and LVT might be
slightly increased (54), and radial strain variations
can differentiate sarcoidosis patients from those with
DCM (55).
Summary: In patients with RCM, GLS is depressed
signiﬁcantly, whereas GRS and GCS might be pre-
served. In amyloid heart disease, beside the
depressed GLS, LV twist and untwist might be pre-
served early and progressively decrease with the
progression of cardiac involvement.
CONSTRICTIVE PERICARDITIS. Constrictive pericar-
ditis (CP) is a pericardial disease with a particular
FIGURE 3 STE Parameters in a Patient With HFpEF Due to Long-Standing Hypertension
Endocardial border tracking for assessment of (A) GLS from the 3 apical views and (B) GCS and GRS from the short axis. (C) Endocardial
border tracking in the short axis at the level of the LV base and apex for assessment of LV rotation and torsion. Although GLS and GRS are
depressed, they are compensated by the relatively normal or increased GCS and LV torsion and thus the preserved ejection fraction.
HFpEF ¼ heart failure with preserved ejection fraction; LAX ¼ measured on the long axis; other abbreviations as in Figures 1 and 2.
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1453clinical importance, because its clinical picture can be
mistaken for RCM, as both involve diastolic dysfunc-
tion with different mechanisms. Thus differentiation
between both conditions is challenging using the
conventional methods. STE-derived deformation im-
aging can usually give a clue to differentiate both
conditions, as different myocardial layers are affected
and thus each case exhibits different mechanical
behaviors. In RCM, endocardial dysfunction causes
depression in GLS and GRS. The relatively spared
epicardial ﬁbers cause preservation of GCS and LVT
(Figures 2A to 2C). In contrast, in CP, mainly the sub-
epicardial ﬁbers are affected with relative sparing of
subendocardial ﬁbers, which leads to preserved GLS
and GRS, whereas GCS and LVT are usually depressed
(Figures 2D to 2F) (44).
Summary: Deformation imaging can be used
to assess patients with pericardial diseases andto differentiate CP from RCM. In CP, the epicardial
dysfunction leads to depressed GCS and LVT, whereas
GLS and GRS are preserved, compared with RCM
where the endocardial dysfunction causes depression
of GLS and GRS with preserved GCS and LVT.
VALVULAR HEART DISEASE. In patients with aortic
stenosis (AS) and preserved EF, the subendocardial
ischemia resulting from the pressure-overload causes
attenuation of GLS with relative preservation or in-
crease in LVT (56). Treatment of AS by surgical or
transcatheter aortic valve replacement cause nor-
malization of all LV mechanics (56,57).
FT-CMR was used to compare the impact of a
transfemoral to a transapical approach of trans-
catheter aortic valve replacement on myocardial me-
chanics (58). No differences in peak radial or
longitudinal strain were found for the basal and
mid-segments. Not surprisingly, in the transapical
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reduced with respect to the transfemoral approach in
the apical segments and the apical cap.
In patients with mitral regurgitation (MR) and
normal EF, the development of insidious myocardial
dysfunction is usually associated with depression in
GLS, GCS, and GRS (59), whereas LVT might be pre-
served until the development of evident reduction of
EF (60). In MR patients undergoing mitral valve
repair, pre-procedural GLS was found to predict post-
procedural EF reduction (61). In patients with sec-
ondary signiﬁcant MR undergoing mitral clip, 3D-STE
showed overall improvement in both LV and RV
strain after clip implantation (62).
In patients with mitral stenosis, GLS and GCS were
found to be lower than in control subjects, with
continuous normalization within 72 h after balloon
mitral valvuloplasty (63). In addition, LVT was found
to be lower in patients with mitral stenosis (64). It is
still controversial whether the basal decrease in LV
mechanics in patients with mitral stenosis is due to
LV dysfunction or as a result of decreased pre-load
caused by the stenosed valve.
Summary: In AS, endocardial dysfunction leads to
depressed GLS, whereas LVT is usually preserved. All
deformation parameters tend to normalize after valve
replacement. In MR, depression of strain parameters
is a sign of insidious systolic dysfunction. GLS can
predict post-mitral valve repair EF reduction.
MYOCARDIAL MECHANICS IN HEART FAILURE. Systolic
heart failure. Symptoms of heart failure can develop
despite preserved EF (i.e., heart failure with pre-
served ejection fraction [HFpEF]). It was previously
believed that the main pathophysiological changes
only involve abnormal diastolic function; however,
LV strain studies have shown that concomitant sys-
tolic abnormalities do occur (15,65). Ongoing pro-
gression of the underlying pathology may result in
abnormalities in strain in all directions resulting into
heart failure with reduced ejection fraction (HFrEF).
STE-based studies have shown that a decreased
GLS can be used as a marker of insidious systolic
function in HFpEF patients and is associated with
higher levels of pro–B-type natriuretic peptide levels
and worse diastolic function (Figure 3A) (66). Exercise
is usually associated with further depression of GLS
and provocation of symptoms in these patients. The
development of abnormal endocardial function early
in the course of heart failure is responsible for the
abnormal longitudinal function. The reason why EF is
preserved in these patients is that GCS and LVT
remain unchanged or even increased (Figures 3B
and 3C), compensating for the decreased GLS. With
the development of HFrEF, GLS continues to decreasetogether with failure of the compensating mecha-
nisms of LVT and GCS, thus myocardial pump failure
and dilation usually ensue (Figure 4).
Summary: In HFpEF, endocardial dysfunction
leads to depressed GLS, which correlates with levels
of pro–B-type natriuretic peptide and diastolic func-
tions. The preserved GCS and LVT usually com-
pensates for the depressed GLS. Failure of these
compensatory mechanisms later in the course of the
disease lead to pump failure (HFrEF).
Diastolic dysfunction and assessment of ﬁlling pressures.
Deformation imaging provides unique information
during the diastolic period that can potentially be
useful in the assessment of diastolic function. This
includes the quantiﬁcation of segmental and global
diastolic strain rate, as well as the differences in the
timing of transition from myocardial contraction to
relaxation with strain rate imaging (67). Whereas
most of these parameters were used in the assess-
ment of regional ﬁbrosis and ischemia, a few studies
have shown a signiﬁcant relation between segmental
and global early diastolic strain rate and the time
constant of LV relaxation (tau) (68,69).
LV diastolic untwist contributes to early LV ﬁlling
through the generation of negative suction pressure
(21). Untwisting parameters were shown to correlate
with invasive indices of LV relaxation and suction
(ﬁrst derivative of pressure measured over time
[dP/dt] and tau) but not with LV stiffness, suggesting
that untwisting is a key mechanical event that aids LV
early diastolic ﬁlling because of serving as a link be-
tween systolic compression and early diastolic recoil
(21,67). Importantly, in cases with abnormal LV
relaxation, untwist duration and time to peak untwist
rate are directly related to tau (21).
However, untwist rate, in addition to LV relaxa-
tion, is also affected by systolic contraction and thus,
changes in untwist rate might not be an accurate
representation of the diastolic dysfunction in patients
with HFpEF.
Although there are plenty of studies concerned
with the assessment of diastolic functions using STE,
there is relatively less data available for the use of
CMR in the assessment of LV diastolic function.
Nevertheless, studies have employed myocardial
tagging to demonstrate abnormalities in LV un-
twisting in diastole in conditions such as asymp-
tomatic individuals with LV hypertrophy and AS
(70). In the MESA (Multi-Ethnic Study of Athero-
sclerosis), CMR tagging was found to be useful in
the assessment of regional diastolic function non-
invasively. In those patients, regional impairment of
early diastolic strain rate was found to occur despite
the preserved systolic function (70,71). Moreover, in
FIGURE 4 STE Parameters in a Patient With HFrEF Due to Long-Standing Hypertension
Endocardial border tracking for assessment of (A) GLS from the 3 apical views and (B) GCS and GRS from the short axis. (C) Endocardial border
tracking in the short axis at the level of LV base and apex for assessment of LV rotation and torsion. All strain values (GLS, GRS, and GCS) as well
as LV torsion are signiﬁcantly depressed, signifying exhaustion of compensation mechanisms. HFrEF ¼ heart failure with reduced ejection
fraction; other abbreviations as in Figures 1 to 3.
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1455a subset of patients in the CARDIA (Coronary Artery
Risk Development in Young Adults) study, diastolic
strain rate calculated from tagged magnetic reso-
nance images was found to predict incident heart
failure and atrial ﬁbrillation (72).
Summary: Tissue tracking parameters can be used
to assess LV relaxation and diastolic function. LV
untwist and strain rate might be promising in this
regard. In patients with diastolic dysfunction, pro-
longed and delayed LV untwist is particularly related
to prolonged LV relaxation and tau and worse LV
diastolic suction.
CLINICAL USE OF DEFORMATION IMAGING IN
OTHER CARDIAC CHAMBERS
RIGHT VENTRICULAR FUNCTION. The use of
RV-LS derived from the RV free wall is currently rec-
ommended for the assessment of RV functions inpatients with suspected RV dysfunctions, such as
congenital abnormalities, arrhythmogenic RV cardio-
myopathy, pulmonary, primary arterial hypertension
(PAH), and pulmonary thromboembolism. In those
patients, RV-LS values are usually decreased and
delayed (73). Interventions that cause improvement of
hemodynamics in these patients are usually accom-
panied by improvement in RV-LS.
In general, RV function derived from STE was
shown to have prognostic value in a variety of
congenital abnormalities (74–76). In patients with
tetralogy of Fallot, RV-LS correlated with exercise
capacity (76).
However, LV affection in patients with RV
dysfunction, as a manifestation of ventricular inter-
dependence, is not uncommon. For instance, in pa-
tients with PAH, LV septal circumferential strain was
found to be affected more than the RV free wall
LS was (77). Moreover, RV strain was found to
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both parameters as a measure of interdependence
might serve as a predictor for future outcome in pa-
tients with PAH (78).
In patients with arrhythmogenic right ventricular
cardiomyopathy (ARVC), compared with control
subjects, RV-LS derived from either STE or FT-CMR
was found to be signiﬁcantly depressed (10,79) and
to be superior to conventional echocardiographic
parameters when used for the diagnosis of these
patients.
It was also found that in patients with ARVC,
compared with control subjects, RV-LS fails to in-
crease with exercise (62). Furthermore, 2D-STE have
suggested a high incidence of LV involvement in
phenotypic patients with ARVC as well as geneti-
cally predisposed relatives. LV involvement in addi-
tion to an enlarged RV outﬂow tract were found to
be independent prognostic markers of event-free
survival (80).
Summary: RV-LS is a recommended measure to
assess RV function in clinical scenarios with sus-
pected RV dysfunction. RV dysfunction caused by
PAH, congenital anomalies, and ARVC is usually
associated by depressed RV-LS. RV-LS is also of
prognostic value in these patients.
Left atrial function. STE and FT-CMR can be also used
to assess LA longitudinal deformations. Because the
LA is a thin-walled chamber, the measurement of the
radial deformation is difﬁcult. LA strain and strain
rate can be used to study LA conduit, contractile, and
reservoir functions (81) and are considered promising
tools that can be used for the assessment of LV ﬁlling
pressures (81,82). In patients with HCM and HFpEF,
FT-CMR–derived total strain and positive strain rates
were reduced and both LA conduit function strain
during ventricular E-wave and ﬁrst negative strain
rate were impaired (12).
In a substudy of MESA, patients had lower atrial
GLS and higher indexed minimal LA volume, both of
which were independently associated with incident
heart failure, even after adjusting for traditional risk
factors, LV mass and N-terminal pro–B-type natri-
uretic peptide (70). FT-CMR–derived LA LS and strain
rate were also found to reliably discriminate between
patients with impaired LV relaxation and healthy
control subjects (12).
LA strain measures, however, are not currently
recommended for routine clinical use and remain
mainly promising research tools, primarily because
most studies concerned with their use are small.
Summary: LA-LS can be assessed by tissue tracking
and is a promising tool that can be used forassessment of LV ﬁlling pressures and atrial function;
however, it still remains as a research tool awaiting
clinical validation.
FUTURE RESEARCH DIRECTIONS
SPECKLE TRACKING ECHOCARDIOGRAPHY. Vari-
ability in most of the STE-derived parameters remains
a great concern and creates difﬁculties in standard-
izing their use and application in everyday clinical
practice (5). The recently initiated European Society
of Cardiovascular Imaging and the American Society
of Echocardiography strain standardization task force
is aiming at addressing the issue of variability by
standardizing the use and applications of STE be-
tween different vendors’ software and users (4).
Importantly, because 3D-STE can simultaneously
measure myocardial motion in all directions, the
introduction of high-resolution 3D systems can be
used for the assessment of myocardial principal strain,
a newly developed concept of studying myocardial
mechanics using 3D echocardiography, which simul-
taneously integrates myocardial deformations in all
directions, alleviating the need for multidirectional
strain assessments (83). In the future, limitations
in the spatial-temporal resolution may be addressed
with the incorporation of high-frequency ultra-
sound systems, which represent a new frontier for
echocardiographic-based deformation imaging that
promises high temporal and spatial resolutions (84).
Finally, appreciation of the LV intracavitary vortex
motion and studying its interaction with myocardial
deformations may open a new era of exploring the
mechanical efﬁciency of cardiac contractions (85).
CMR FEATURE TRACKING. As opposed to speckle
tracking, FT-CMR has not been validated in the
setting of phantoms or animal models to compare
with ground truth assessment of myocardial defor-
mation by, for example, crystals.
In many pathologies, early subclinical changes are
detected by changes of LS. However, because GLS and
especially global RV-LS are less reproducible than
GCS is, optimization of the longitudinal tracking will
be necessary to be applicable in the individual pa-
tient. The major advantage of FT-CMR is that it does
not require special sequences and can be applied
retrospectively. Therefore, it can be expected that
this technique will see a large increase in published
studies, as was the case after the introduction of STE
replacing the tissue Doppler-based strain imaging
techniques.
As opposed to STE (6), most FT-CMR studies
have been using the same software for analysis,
limiting this potential source of variability. It can be
TABLE 4 Patterns of Myocardial Deformation in Different Cardiovascular Diseases
GLS GRS GCS LVT LV-UTR
Cardiac risk factor–induced subclinical
myocardial dysfunction
Y Y Normal or[ Normal or [ Normal or Y
Ischemic heart disease Y Y Normal or [ Normal or [ Delayed/may Y
Dilated cardiomyopathy Y Y Y Y Y
LV noncompaction Y Y Y Absent Absent
Hypertrophic cardiomyopathy Y Y Normal or [ Normal or [ Delayed/may Y
Restrictive cardiomyopathy Y Y Y Y Y
Constrictive pericarditis Normal Normal Y Y Y
Aortic stenosis Y Y Normal or [ Normal or [ Delayed/may Y
Mitral regurgitation Y Y Normal or [ Normal or [ Delayed/may Y
Heart failure preserved ejection fraction Y Y Normal or [ Normal or [ Normal or Y
Heart failure reduced ejection fraction Y Y Y Y Y
Y ¼ decrease; [ ¼ increase; UTR ¼ untwist rate; other abbreviations as in Tables 2 and 3.
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1457expected that when FT-CMR enters more into the
clinical arena, new software will emerge and similar
efforts of standardization like with STE will be
needed (4).
There is a large transmural gradient (from endo-
cardium to epicardium) of circumferential strain and
a slightly different initial contour placement will in-
ﬂuence circumferential strain values. The optimal
choice here remains unknown and will need to be
determined by further research or consensus. In
this context, it is also important to remember that
FT-CMR derives its information mainly from the
endocardial border, as opposed to intramyocardial
speckles as used for STE.
FT-CMR offers the possibility to use historical cine
data. Although the effect of frame rate has not been
studied, so far the standard frame rate used in CMR
(usually approximately 30 frames/cardiac cycle) is
below the recommended frame rates for STE, which
may induce signiﬁcant differences especially when
considering strain rate values.
CONCLUSIONS
Both STE and FT-CMR currently offer reproducible
measurements of global strain values that can beapplied in different clinical scenarios to assess LV
and RV function (Table 4). CMR has an established
and continuously expanding role in tissue charac-
terization and is the modality of choice for accurate
evaluation of global function using volumetry.
Whether the additional assessment of myocardial
deformation yields information beyond direct tissue
characterization remains to be evaluated. Similarly,
the yield of STE versus CMR tissue characterization
needs to be assessed. Most likely, a major clinical
value of these techniques will only be achieved
when a reliable segmental analysis becomes
possible. For the time being, GLS in 2D-STE has a
proven clinical value due to its sensitivity to early
contractile changes in the presence of normal or
preserved EF.
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